Comprehensive exploratory autoantibody profiling in patients with early rheumatoid arthritis treated with methotrexate or tocilizumab

BACKGROUND: We sought to identify immunoglobin G autoantibodies predictive of early treatment response to methotrexate, the recommended first-line therapy for patients with newly diagnosed rheumatoid arthritis, and to the interleukin-6 receptor inhibitor biologic tocilizumab, initiated as the first...

Descripción completa

Detalles Bibliográficos
Autores principales: Teitsma, Xavier M., Devenport, Jenny, Jacobs, Johannes W. G., Pethö-Schramm, Attila, Borm, Michelle E. A., Budde, Petra, Bijlsma, Johannes W. J., Lafeber, Floris P. J. G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7728181/
https://www.ncbi.nlm.nih.gov/pubmed/33301475
http://dx.doi.org/10.1371/journal.pone.0241189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7728181/
https://www.ncbi.nlm.nih.gov/pubmed/33301475
http://dx.doi.org/10.1371/journal.pone.0241189

Ejemplares similares